Press "Enter" to skip to content

Despite Reporting Data For A Mid-Stage Study, La Jolla Has Several Other Irons In The Fire For 2019 – Seeking Alpha

admin 0

Despite Reporting Data For A Mid-Stage Study, La Jolla Has Several Other Irons In The Fire For 2019  Seeking Alpha

La Jolla Pharmaceutical announced positive results from its phase 2 study using LJPC-401 to treat patients with hereditary hemochromatosis. There will be final.

“liver cancer” – Google News

(Visited 1 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *